aTYR PHARMA INC ATYR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-05-07
aTYR PHARMA INC institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 1,392,074 | $2.2M |
| MILLENNIUM MANAGEMENT LLC | 1,641,246 | $1.3M |
| TWO SIGMA INVESTMENTS, LP | 1,144,565 | $892,761 |
| AQR CAPITAL MANAGEMENT LLC | 496,018 | $386,894 |
| CITADEL ADVISORS LLC | 203,372 | $158,630 |
| RENAISSANCE TECHNOLOGIES LLC | 40,522 | $31,607 |
Source: SEC EDGAR filings · CIK 0001339970 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.